FDA
approval
· 2025-03-05
FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for levetiracetam in sodium chloride, a new injectable formulation by Hikma Pharmaceuticals USA Inc., expanding availabl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM IN SODIUM CHLORIDE)